Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04582942
Other study ID # 2019-X2-73
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 6, 2020
Est. completion date August 15, 2021

Study information

Verified date December 2022
Source Renmin Hospital of Wuhan University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of polyethylene glycol(PEG) combined with lactulose for bowel preparation before colonoscopy in low-risk patients and high-risk patients.


Description:

The quality of bowel preparation is crucial for colonoscopy. Some high-risk factors for inadequate bowel preparation have been identified , including age >70, previous colon surgery, constipation, diabetes, Parkinson's disease, history of stroke or spinal cord injury, prior history of inadequate bowel preparation, body mass index (BMI) >25, use of tricyclic antidepressant or narcotics. Patients were considered as high risk if they have any of the above factors and considered as low risk if they did not have any of these risk factors.This is a multicenter, endoscopist-blinded study to compare the efficacy of PEG combined with lactulose and PEG alone in bowel preparation. In colonoscopy procedures, endoscopists who were blinded to the intervention evaluated the overall quality of colonoscopy cleaning according to the Boston Bowel Preparation Scale. Patients' tolerance, defecation, adverse events and adenoma detection rate (ADR) were also evaluated.


Recruitment information / eligibility

Status Completed
Enrollment 2028
Est. completion date August 15, 2021
Est. primary completion date August 15, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults undergoing colonoscopy. Exclusion Criteria: - 1.presence of any contraindications for colonoscopy (gastrointestinal obstruction or perforation,severe acute inflammatory bowel disease,toxic megacolon,severe heart failure,unable to swallow,severe heart failure,etc); - 2.Patients with galactosemia; - 3. hypersensitivity to any of the ingredients; - 4.Pregnancy or lactation; - 5.Use of lactulose,prokinetic agents or purgatives within 7 days; - 6.Unwilling to sign informed consent.

Study Design


Related Conditions & MeSH terms

  • Bowel Preparation Before Colonoscopy

Intervention

Drug:
PEG
Patients began to drink 1 L of PEG at 8:00 PM on the day before colonoscopy at a rate of 250 mL every 10- 15 minutes. On the day of the procedure, patients took the remaining 2 L of PEG 4-6 hours before colonoscopy.
PEG+lactulose
On the day before colonoscopy , Patients took 45 mL lactulose solution at 7:00 PM. And then Patients began to drink 1 L of PEG at 8:00 PM at a rate of 250 mL every 10- 15 minutes. On the day of the procedure, patients took 45 mL lactulose solution and the remaining 2 L of PEG 4-6 hours before colonoscopy.

Locations

Country Name City State
China Renmin Hospital of Wuhan University Wuhan Hubei

Sponsors (10)

Lead Sponsor Collaborator
Renmin Hospital of Wuhan University Hubei Hospital of Traditional Chinese Medicine, The General Hospital of Central Theater Command, The Third People's Hospital of Hubei Province, Tian You Hospital Affiliated to Wuhan University of Science and Technology, Wuhan Central Hospital, Wuhan Puai Hospital, Wuhan Puren Hospital, Wuhan Red Cross Hospital, Wuhan Third Hospital

Country where clinical trial is conducted

China, 

References & Publications (5)

ASGE Standards of Practice Committee, Saltzman JR, Cash BD, Pasha SF, Early DS, Muthusamy VR, Khashab MA, Chathadi KV, Fanelli RD, Chandrasekhara V, Lightdale JR, Fonkalsrud L, Shergill AK, Hwang JH, Decker GA, Jue TL, Sharaf R, Fisher DA, Evans JA, Foley K, Shaukat A, Eloubeidi MA, Faulx AL, Wang A, Acosta RD. Bowel preparation before colonoscopy. Gastrointest Endosc. 2015 Apr;81(4):781-94. doi: 10.1016/j.gie.2014.09.048. Epub 2015 Jan 14. No abstract available. — View Citation

Bai Y, Fang J, Zhao SB, Wang D, Li YQ, Shi RH, Sun ZQ, Sun MJ, Ji F, Si JM, Li ZS. Impact of preprocedure simethicone on adenoma detection rate during colonoscopy: a multicenter, endoscopist-blinded randomized controlled trial. Endoscopy. 2018 Feb;50(2):128-136. doi: 10.1055/s-0043-119213. Epub 2017 Oct 6. — View Citation

Hassan C, East J, Radaelli F, Spada C, Benamouzig R, Bisschops R, Bretthauer M, Dekker E, Dinis-Ribeiro M, Ferlitsch M, Fuccio L, Awadie H, Gralnek I, Jover R, Kaminski MF, Pellise M, Triantafyllou K, Vanella G, Mangas-Sanjuan C, Frazzoni L, Van Hooft JE, Dumonceau JM. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2019. Endoscopy. 2019 Aug;51(8):775-794. doi: 10.1055/a-0959-0505. Epub 2019 Jul 11. — View Citation

Kang X, Zhao L, Zhu Z, Leung F, Wang L, Wang X, Luo H, Zhang L, Dong T, Li P, Chen Z, Ren G, Jia H, Guo X, Pan Y, Guo X, Fan D. Same-Day Single Dose of 2 Liter Polyethylene Glycol is Not Inferior to The Standard Bowel Preparation Regimen in Low-Risk Patients: A Randomized, Controlled Trial. Am J Gastroenterol. 2018 Apr;113(4):601-610. doi: 10.1038/ajg.2018.25. Epub 2018 Mar 13. — View Citation

Lu J, Cao Q, Wang X, Pu J, Peng X. Application of Oral Lactulose in Combination With Polyethylene Glycol Electrolyte Powder for Colonoscopy Bowel Preparation in Patients With Constipation. Am J Ther. 2016 Jul-Aug;23(4):e1020-4. doi: 10.1097/MJT.0000000000000351. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Boston Bowel Preparation Scale Cleanliness of the colon during colonoscopy will be evaluated by the Boston Bowel Preparation Scale which is a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side. The total BBPS score ranged from 0 to 9. If total BostonBowel Preparation Score =6 with each segmental BBPS=2, we regard it as adequate bowel preparation. during colonoscopy
Secondary Adenoma Detection Rate Diagnosis was confirmed by histologic examination 2 days
Secondary Rate of adverse events adverse events, such as vomiting, nausea, headache, abdominal distention,abdominal pain. 2 days
Secondary Cecal intubation rate Colonoscopy reaches cecal region. during colonoscopy
Secondary Cecal intubation time Colonoscopy reaches cecal region. during colonoscopy
Secondary Withdrawal time The time from the cecum to the anus, but excluded time for biopsy performance or removal of polyps. during colonoscopy
Secondary defecation frequency Frequency of bowel movement. 2 days
Secondary Willingness to repeat bowel preparation The number of patients have a willingness to undergo a repeated bowel preparation if needed. 2 days
See also
  Status Clinical Trial Phase
Completed NCT01984008 - A Study of the Efficacy and Safety of Bowklean and Klean-Prep With Dulcolax for the Bowel Preparation Prior Colonoscopy Phase 3
Recruiting NCT05498714 - Improved Bowel Cleansing Method for Colonoscopy Based on High Risk Population of Bowel Preparation N/A
Completed NCT01745835 - Comparison Between 2L Coolprep® and Combination of 1L Coolprep® and Bisacodyl as Bowel Preparation Phase 3
Completed NCT02910440 - A Safety and Efficacy Study of DCL-101 Compared to GoLYTELY Phase 2
Recruiting NCT05054036 - MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy Phase 4
Recruiting NCT03106922 - A Trial to Evaluate the Efficacy and Safety of PMF104 Compared to a Conventional PEG-electrolyte Solution in Children Phase 3